Ken Griffin Kodiak Sciences Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 7,600 shares of KOD stock, worth $19,608. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,600

Previous 36,700 79.29%

Holding current value

$19,608

Previous $193,000 91.19%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$3.01 - $7.45 $158,672 - $392,726	-52,715 Reduced 96.12%	2,128 $11,000
Q4 2023 Feb 14, 2024	SELL	$1.4 - $3.24 $518,030 - $1.2 Million	-370,022 Reduced 87.09%	54,843 $166,000
Q3 2023 Nov 14, 2023	BUY	$1.8 - $7.49 $111,211 - $462,762	61,784 Added 17.02%	424,865 $764,000
Q2 2023 Aug 14, 2023	SELL	$4.3 - $9.48 $2.27 Million - $5.01 Million	-528,017 Reduced 59.25%	363,081 $2.51 Million
Q1 2023 May 15, 2023	BUY	$4.81 - $8.88 $2.8 Million - $5.16 Million	581,311 Added 187.65%	891,098 $5.52 Million
Q4 2022 Feb 14, 2023	BUY	$6.52 - $8.05 $562,532 - $694,537	86,278 Added 38.6%	309,787 $2.22 Million
Q3 2022 Nov 14, 2022	BUY	$7.57 - $12.5 $762,692 - $1.26 Million	100,752 Added 82.07%	223,509 $1.73 Million
Q2 2022 Aug 15, 2022	SELL	$5.04 - $9.48 $589,231 - $1.11 Million	-116,911 Reduced 48.78%	122,757 $938,000
Q1 2022 May 16, 2022	BUY	$7.09 - $89.45 $983,099 - $12.4 Million	138,660 Added 137.28%	239,668 $1.85 Million
Q4 2021 Feb 14, 2022	BUY	$80.85 - $128.49 $2.45 Million - $3.9 Million	30,325 Added 42.9%	101,008 $8.56 Million
Q3 2021 Nov 15, 2021	SELL	$81.97 - $106.94 $1.78 Million - $2.33 Million	-21,759 Reduced 23.54%	70,683 $6.78 Million
Q2 2021 Aug 16, 2021	SELL	$77.2 - $126.54 $2.55 Million - $4.19 Million	-33,086 Reduced 26.36%	92,442 $8.6 Million
Q1 2021 May 17, 2021	BUY	$110.45 - $164.47 $10.7 Million - $16 Million	97,153 Added 342.39%	125,528 $14.2 Million
Q4 2020 Feb 16, 2021	SELL	$60.78 - $154.03 $736,349 - $1.87 Million	-12,115 Reduced 29.92%	28,375 $4.17 Million
Q3 2020 Nov 16, 2020	BUY	$45.05 - $59.27 $458,518 - $603,250	10,178 Added 33.58%	40,490 $2.4 Million
Q2 2020 Aug 14, 2020	SELL	$42.74 - $66.25 $2.87 Million - $4.44 Million	-67,089 Reduced 68.88%	30,312 $1.64 Million
Q1 2020 May 15, 2020	BUY	$38.18 - $73.95 $3.18 Million - $6.17 Million	83,385 Added 594.93%	97,401 $4.65 Million
Q2 2019 Aug 14, 2019	BUY	$6.2 - $12.0 $86,899 - $168,192	14,016 New	14,016 $164,000

Others Institutions Holding KOD

# of Institutions

104

Shares Held

39.8M

Call Options Held

7.6K

Put Options Held

3.5K

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $134M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account